Archimica Overview

  • Year Founded
  • 1947

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 128

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 6

  • Investments
  • 5

Archimica General Information

Description

Manufacturer of active pharmaceutical ingredients (API) and late-stage intermediates for the pharmaceutical industry. The company's products include reagents and building blocks, regulatory starting materials, cGMP intermediates, and active pharmaceutical ingredients.

Contact Information

Formerly Known As
Prime European Therapeuticals, Euticals, Istituto Chemioterapico Italiano
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Corporate Office
  • Viale Milano, 86
  • 26900 Lodi
  • Italy
+39 0371
Primary Industry
Pharmaceuticals
Parent Company
Corporate Office
  • Viale Milano, 86
  • 26900 Lodi
  • Italy
+39 0371

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Archimica Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Archimica‘s full profile, request access.

Request a free trial

Archimica Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of active pharmaceutical ingredients (API) and late-stage intermediates for the pharmaceutical industry. Th
Pharmaceuticals
Lodi, Italy
128 As of 2026

Sant Joan Despí, Spain
 

Vicenza, Italy
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Archimica Competitors (6)

One of Archimica’s 6 competitors is Medichem Spain, a Corporation company based in Sant Joan Despí, Spain.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Medichem Spain Corporation Sant Joan Despí, Spain
Fabbrica Italiana Sintetici Private Equity-Backed Vicenza, Italy
Dipharma Corporation Milan, Italy
Erregierre Corporation San Paolo D'argon, Italy
CPL SACHSE Corporation Berlin, Germany
To view Archimica’s complete competitors history, request access »

Archimica Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Archimica Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Archimica‘s full profile, request access.

Request a free trial

Archimica Investments & Acquisitions (5)

Archimica’s most recent deal was a Buyout/LBO with Archimica (acquired). The deal was made on 14-Feb-2011.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Archimica (acquired) 14-Feb-2011 Buyout/LBO Pharmaceuticals
Suzhou Tianma Group Tianji Bio-Pharmaceutical Company 01-Dec-2010 PE Growth/Expansion Other Pharmaceuticals and Biotechnology
Polichimica 09-Mar-2010 Buyout/LBO Distributors (Healthcare)
Diaspa 04-Apr-2002 Merger/Acquisition Other Commercial Services
Diaspa 29-Dec-1997 Merger/Acquisition Other Commercial Services
To view Archimica’s complete investments and acquisitions history, request access »

Archimica Exits (3)

Archimica’s most recent exit was on 01-Dec-2010 from Suzhou Tianma Group Tianji Bio-Pharmaceutical Company. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Suzhou Tianma Group Tianji Bio-Pharmaceutical Company 01-Dec-2010 Completed
  • 2 buyers
Diaspa 04-Apr-2002 Completed
Diaspa 29-Dec-1997 Merger/Acquisition Completed
  • 2 buyers
To view Archimica’s complete exits history, request access »

Archimica FAQs

  • When was Archimica founded?

    Archimica was founded in 1947.

  • Where is Archimica headquartered?

    Archimica is headquartered in Lodi, Italy.

  • What is the size of Archimica?

    Archimica has 128 total employees.

  • What industry is Archimica in?

    Archimica’s primary industry is Pharmaceuticals.

  • Is Archimica a private or public company?

    Archimica is a Private company.

  • What is the current valuation of Archimica?

    The current valuation of Archimica is .

  • What is Archimica’s current revenue?

    The current revenue for Archimica is .

  • How much funding has Archimica raised over time?

    Archimica has raised $108M.

  • Who are Archimica’s investors?

    Clessidra Private Equity, Curia, DeA Capital Alternative Funds, LÖW, and Mindful Capital Partners are 5 of 6 investors who have invested in Archimica.

  • Who are Archimica’s competitors?

    Medichem Spain, Fabbrica Italiana Sintetici, Dipharma, Erregierre, and CPL SACHSE are some of the 6 competitors of Archimica.

  • When was Archimica acquired?

    Archimica was acquired on 27-Apr-2023.

  • Who acquired Archimica?

    Archimica was acquired by PI Industries.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process